NewEdge Wealth’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.23M | Buy |
11,499
+161
| +1% | +$73.2K | 0.08% | 191 |
|
|
2025
Q1 | $5.64M | Sell |
11,338
-2,626
| -19% | -$1.31M | 0.1% | 166 |
|
|
2024
Q4 | $7.26M | Buy |
13,964
+797
| +6% | +$415K | 0.13% | 140 |
|
|
2024
Q3 | $8.14M | Buy |
13,167
+7,429
| +129% | +$4.6M | 0.15% | 139 |
|
|
2024
Q2 | $3.17M | Sell |
5,738
-446
| -7% | -$247K | 0.07% | 236 |
|
|
2024
Q1 | $3.53M | Buy |
6,184
+648
| +12% | +$370K | 0.08% | 213 |
|
|
2023
Q4 | $2.94M | Sell |
5,536
-395
| -7% | -$210K | 0.08% | 229 |
|
|
2023
Q3 | $3M | Sell |
5,931
-1,121
| -16% | -$567K | 0.1% | 183 |
|
|
2023
Q2 | $3.68M | Buy |
7,052
+3,521
| +100% | +$1.84M | 0.12% | 152 |
|
|
2023
Q1 | $2.04M | Sell |
3,531
-246
| -7% | -$142K | 0.08% | 220 |
|
|
2022
Q4 | $2.08M | Buy |
3,777
+952
| +34% | +$524K | 0.09% | 205 |
|
|
2022
Q3 | $1.43M | Sell |
2,825
-549
| -16% | -$278K | 0.07% | 235 |
|
|
2022
Q2 | $1.83M | Buy |
3,374
+1,016
| +43% | +$552K | 0.08% | 200 |
|
|
2022
Q1 | $1.39M | Buy |
2,358
+1,448
| +159% | +$855K | 0.06% | 192 |
|
|
2021
Q4 | $607K | Buy |
910
+216
| +31% | +$144K | 0.03% | 272 |
|
|
2021
Q3 | $397K | Sell |
694
-423
| -38% | -$242K | 0.02% | 227 |
|
|
2021
Q2 | $563K | Sell |
1,117
-17,060
| -94% | -$8.6M | 0.04% | 210 |
|
|
2021
Q1 | $8.3M | Buy |
18,177
+12,937
| +247% | +$5.9M | 0.82% | 32 |
|
|
2020
Q4 | $2.44M | Buy |
+5,240
| New | +$2.44M | 0.75% | 34 |
|